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Abstract
Background: Inexpensive, reliable objective methods are needed to measure physical activity (PA) in large scale
trials. This study compared the number of pedometer step counts with accelerometer data in pregnant women in
free-living conditions to assess agreement between these measures.
Methods: Pregnant women (n = 58) with body mass index ≥25 kg/m
2 at median 13 weeks’ gestation wore a
GT1M Actigraph accelerometer and a Yamax Digi-Walker CW-701 pedometer for four consecutive days. The
Spearman rank correlation coefficients were determined between pedometer step counts and various
accelerometer measures of PA. Total agreement between accelerometer and pedometer step counts was evaluated
by determining the 95% limits of agreement estimated using a regression-based method. Agreement between the
monitors in categorising participants as active or inactive was assessed by determining Kappa.
Results: Pedometer step counts correlated moderately (r = 0.36 to 0.54) with most accelerometer measures of PA.
Overall step counts recorded by the pedometer and the accelerometer were not significantly different (medians
5961 vs. 5687 steps/day, p = 0.37). However, the 95% limits of agreement ranged from -2690 to 2656 steps/day for
the mean step count value (6026 steps/day) and changed substantially over the range of values. Agreement
between the monitors in categorising participants to active and inactive varied from moderate to good depending
on the criteria adopted.
Conclusions: Despite statistically significant correlations and similar median step counts, the overall agreement
between pedometer and accelerometer step counts was poor and varied with activity level. Pedometer and
accelerometer steps cannot be used interchangeably in overweight and obese pregnant women.
Background
Current recommendations emphasize that regular mod-
erate intensity leisure-time physical activity (PA) during
an uncomplicated pregnancy may have benefits such as
reducing fatigue, back pain, stress and depression and
improving glycaemic control, but has no known harmful
effects on the health of the mother or the fetus [1,2].
However, the available evidence is limited and larger
and better quality trials are needed to define the poten-
tial role for PA promotion in preventing pregnancy
complications such as gestational diabetes and pre-
eclampsia [3].
Most previous studies assessing PA in relation to
pregnancy outcome have used questionnaires or other
self-reported measurements of PA, as these are cheap to
administer in large scale studies [4]. Although some of
the questionnaires have been validated in pregnant
women either against accelerometer [5-7], a portable
activity monitor [8] or pedometer and a PA log book
[9], their validity has usually been low or moderate,
especially with regard to the light intensity activity that
is common among pregnant women [10]. These limita-
tions are also observed for PA questionnaires in other
populations [11,12]. Therefore, inexpensive, objective
PA measurement methods are needed for large scale
studies to obtain more accurate information on PA
levels during pregnancy.
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monly used objective methods of assessing PA in epide-
miologic studies, and have been used in a number of
previous studies of pregnant women [5,6,10,13-16].
While accelerometers provide more detailed information
on PA than pedometers, pedometers are much less
expensive and therefore more economically feasible for
larger studies [17]. It is unclear whether pedometers and
accelerometers provide comparable estimates of PA in
pregnant women. This issue was recently explored in
two small studies (n = 30 in both of them) examining
pregnant women in free-living conditions [18] and on a
treadmill [19]. Similar comparisons have also been
reported in healthy adults [20,21] adults with human
immunodeficiency virus [22] and older people [23] in
free-living conditions. These studies suggest that ped-
ometer and accelerometer step counts are highly corre-
lated, but large individual differences in step counts
exist. Nevertheless, pedometer step counts for assessing
overall PA were advocated in most of these studies
[18,21-23].
This study was designed as a preliminary investigation
to determine appropriate PA measurement methods for
a large randomised controlled trial of a lifestyle inter-
vention in obese pregnant women. Overweight and
obese women have a higher risk of several pregnancy
complications and may benefit from increasing their PA
levels during pregnancy [24,25]. The aim of this study
was to compare pedometer step counts with several
accelerometer-derived measures of PA in overweight
and obese pregnant women in free-living conditions.
Methods
Study participants
Participants were overweight and obese pregnant
women with body mass index (BMI) at least 25 kg/m
2
based on self-reported height and measured weight at
the first visit to antenatal care, usually before 12 weeks’
gestation. The exclusion criteria were BMI less than 25
kg/m
2, age less than 16 years, multiple pregnancy,
abnormal ultrasound scan result, complicated medical
problems, inadequate language skills in English, or
inability to give written informed consent. A research
midwife recruited the participants when they attended
for their routine ultrasound scan at either 11-14 or ≥20
weeks’ gestation at the Royal Victoria Infirmary, New-
castle upon Tyne, UK, between July and December
2009. The participants were recruited in early pregnancy
because information on appropriate PA measurement
methods for the intervention study starting in early
pregnancy was needed.
A total of 286 women were eligible for the study and
93 (33%) agreed to participate. All participants signed a
written informed consent for participation. Ethical
a p p r o v a lf o rt h es t u d yw a so b t a i n e df r o mS tT h o m a s ’s
Hospital Research Ethics Committee, London, UK
(National Research Ethics Service, REC reference 09/
H0802/5).
Data collection
This study was a cross-sectional comparison of two
objective PA measurement methods. The research mid-
wife asked participants to wear an accelerometer and a
pedometer for four consecutive days, including one
weekend day. In adults, three to five days of monitoring
by accelerometer usually provides a reliable estimate of
PA [26]. The participants kept a diary to record when
the monitors were put on and when they were taken off.
Data on participants’ demographic details were collected
using a short structured questionnaire. An appointment
for returning the monitors was arranged after the four-
day period.
Accelerometer
The GT1M Actigraph accelerometer used in this study
is a small uniaxial monitor, which detects vertical accel-
erations over a user-specific time interval (epochs) [27].
The former version of the Actigraph accelerometer
(Computer Science and Applications (CSA) 7164 model)
is one of the most extensively validated accelerometers
and its activity counts correlate reasonably with doubly
labelled water derived energy expenditure in non-preg-
nant populations [28].
Participants were asked to wear the accelerometer on
the right hip during waking hours except while swim-
ming or having a shower or bath. They were given the
choice of belt or waistband attachment and information
was recorded on which they found to be the most com-
fortable. Most participants (n = 40, 69%) wore the accel-
erometer using a belt, while 14 (24%) clipped it on the
waistband of their clothing and the status was unknown
for four participants (7%). A 60-second epoch length
was used in this study. The raw data was processed
using the MAHuffe program (http://www.mrc-epid.cam.
ac.uk/Research/Programmes/Programme_5/InDepth/
Programme%205_Downloads.html). Periods of at least
60 min with no counts and days with less than 500 min
of total valid recording time were excluded.
The following cut points were used to assess time
spent at different intensity levels: sedentary activity <100
counts/min [29], light activity 100-1951 counts/min,
moderate activity 1952-5724 counts/min and vigorous
activity >5724 counts/min [30]. These cut points were
originally developed for CSA Model 7164 accelerometer.
Currently there is no consensus on the best cut points
to be used and these may vary in different populations.
The Freedson cut points, derived from treadmill condi-
tions, were selected because leisure time PA in our
population mainly consisted of walking and because
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comparing pedometers to accelerometers [18,20-22].
Pedometer
The Yamax Digi-Walker CW-701 (Yamax, Corp) was
used to measure daily step counts. Yamax Digi-Walker
models have been shown to be among the most accurate
models in measuring step counts [31,32]. The partici-
pants were asked to wear this device during the same
time period as the accelerometer. The participants
clipped the pedometer either to the accelerometer belt
or to the waistband of their clothing depending on how
the accelerometer was attached.
Categorising participants as active or inactive
Three different criteria were used to categorise partici-
p a n t sa sa c t i v e :1 )≥30 min MVPA/day (for acceler-
ometer data only as this information could not be
derived from the pedometer data), 2) ≥10,000 steps/day
and 3) ≥8,000 steps/day. The first criterion was based
on current PA recommendations [1,2]. The second cri-
terion is a commonly used step target in health promo-
tion and has been shown to be associated with health
benefits [33,34]. The third criterion was chosen as there
is some evidence to suggest that 8000 steps/day corre-
sponds to 30 min of MVPA/day measured by acceler-
ometer when using similar intensity cut points as in the
present study [20,21,34].
Statistical analyses
All activity data was averaged over the valid days of
recording. The majority of variables were not normally
distributed and therefore non-parametric methods were
employed for all analyses. Continuous variables were
described using the median and inter-quartile range.
Differences in background characteristics of included (n
= 58) and excluded (n = 35) participants were tested
using Mann-Whitney U test for continuous variables
and c
2-test for categorised variables.
Agreement between the accelerometer and the ped-
ometer was assessed in several ways. Absolute step-count
measurements were compared using the Wilcoxon
Signed-Rank Test. The relative agreement between ped-
ometer-derived step-counts and various accelerometer
measures of PA was examined by determination of the
Spearman rank correlation coefficient (r).
Total agreement between accelerometer-derived and
pedometer-derived step-counts was evaluated by deter-
mination of the 95% limits of agreement. The difference
between both measures of step counts was plotted
against the mean of both measures. Since there was a
statistically significant negative correlation between
these variables, which was not resolved by transforma-
tion, the limits of agreement were estimated by a regres-
sion-based method [35]. To test whether the limits of
agreement varied by baseline BMI (25.0-29.9 kg/m
2 vs.
≥30.0 kg/m
2) or gestational age (11-14 vs. ≥20 weeks’
gestation), interactions terms were added to regression
models, and absolute residuals were compared by Stu-
dent’s t-tests.
The classification of participants according to whether
or not they recorded a daily mean of at least 8,000 or
10,000 steps/day was compared between pedometer and
accelerometer by calculating Cohen’s kappa over 2 × 2
contingency tables. Kappa was also determined to assess
the agreement between those reaching 8,000 pedometer
steps/day and those achieving 30 mins MVPA measured
by accelerometer. Kappa values 0.81-1.00 were regarded
as almost perfect, 0.61-0.80 good, 0.41-0.60 moderate,
0.21-0.40 fair and 0.0-0.20 slight [36].
P-values and confidence intervals for r were estimated
by bootstrapping over 5,000 iterations. P < 0.05 was
considered statistically significant. The majority of statis-
tical analyses were performed using SPSS 17.0 for Win-
dows (SPSS Inc., IL), however bootstrapping methods
used Stata 10.2 (StataCorp, TX).
Results
Of the 93 women recruited, 32 (34%) had less than
three valid days of accelerometer data, 17 (18%) had
three and 44 (47%) had four days. All valid days from
women with at least three valid days (n = 61) were
included in further analyses, excluding three women
who did not have pedometer data. The final study sam-
ple consisted of 58 women (62% of those recruited).
The excluded women (n = 35) were younger (medians
28 vs. 32 years, p = 0.018), more often smokers during
the previous year (46 vs. 13%, p = 0.002) and fewer of
them were highly educated (5 vs. 59%, p < 0.001), but
gestational age, BMI, parity, ethnicity, marital status and
employment status were similar to those of the included
women. The background characteristics of the included
w o m e na r ed e s c r i b e di nT a b l e1 .T h em e d i a na g ew a s
32 years and median BMI 29.3 kg/m
2 (range from 25.3
to 46.2 kg/m
2).
Descriptive activity data
The median wear time of the accelerometer was 13
hours 40 min/day (Table 2). The women were sedentary
for most of that time and total active time (median 4
hours 50 min/day) mainly comprised of light intensity
activity. The median time spent in MVPA was 18 min/
day.
Agreement between continuous pedometer and
accelerometer measures of PA
There was no significant difference between the overall
step counts recorded by the pedometer and the acceler-
ometer (medians 5961 vs. 5687 steps/day, p = 0.37,
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related with all accelerometer measures of PA except for
s e d e n t a r yt i m e( T a b l e3 ) .T h e correlation was good for
accelerometer step counts (r = 0.78) and moderate (r =
0.36 to 0.54) for all other measures of PA. Pedometer
step counts are plotted against accelerometer step
counts in Figure 1.
Despite these statistically significant correlations, the
95% limits of agreement were very broad, ranging
between -2690 to 2656 steps/day for the mean value
(mean of accelerometer and pedometer steps/day =
6026) (Figure 2). The limits of agreement also varied
substantially over the range of values, indicating a differ-
ential bias. At the lowest recorded step count (mean of
accelerometer and pedometer steps/day = 906), the lim-
its were -927 to 4897 steps/day (a range of 5,824), indi-
cating that the accelerometer was on average recording
more steps/day than the pedometer. In contrast, at the
highest step count value (mean of accelerometer and
pedometer steps/day = 12,018) the limits were -4753 to
33 steps/day (a range of 4,786) indicating that while the
level of random disagreement had decreased, the direc-
tion of bias had reversed, with the accelerometer record-
ing less steps/day than the pedometer on average.
BMI and gestational age did not modify the limits of
agreement as there were no statistically significant dif-
ferences in the slope of the regression line (p = 0.28 for
BMI, p = 0.68 for gestational age) or in the absolute
Table 1 Background characteristics of the participants
Participants
Continuous variables, medians (interquartile range)
1
Age, years 32 (27-36)
Weeks’ gestation 13 (12-20)
Body mass index, kg/m
2 29.3 (27.5-33.8)
Categorized variables, numbers (%)
Weeks’ gestation category
11-14 32 (55.2)
≥20 26 (44.8)
BMI category
25.0-29.9 kg/m
2 35 (60.3)
≥30.0 kg/m
2 22 (39.7)
Parity
0 27 (46.6)
1 21 (36.2)
≥2 10 (17.2)
Education (highest qualification)
2
GCSE or equivalent (at age ≥16 years) 9 (17.0)
A level or equivalent (at age ≥18 years) 13 (24.5)
Degree or higher postgraduate qualification 31 (58.5)
Ethnicity
White 48 (88.9)
Other 6 (11.1)
Smoked during the last year
Yes 7 (12.7)
No 48 (87.3)
Employed at the beginning of pregnancy
Yes 48 (84.2)
No 9 (15.8)
Hours of employment
3
Full time (≥37 h/week) 30 (63.8)
Part time (<37 h/week) 17 (36.2)
Living with a partner/husband
Yes 55 (96.5)
No 2 (3.5)
1 n = 58 for continuous variables.
2 GCSE: General Certificate of Secondary Education. Higher postgraduate
qualification includes Professional Graduate Certificate in Education (or
Postgraduate Certificate in Education), MSc, PhD etc.
3 including 48 women who were employed.
Table 2 Descriptive data on physical activity measures
among participants with at least 3 valid days (n = 58)
1
Median (interquartile
range)
Range
Accelerometer
Total included wearing
time
2
821.8 (754.0-869.3) 608.0-1,111.0
Sedentary time
2 514.0 (464.3-583.1) 255.7-849.8
Total activity time
2 290.9 (245.8-340.1) 125.7-473-5
Light activity
2 271.3 (218.8-315.4) 99.3-429.3
Moderate activity 18.0 (11.4-29.1) 5.3-70.0
Vigorous activity 0.0 (0.0-0.0) 0.0-4.3
Moderate or vigorous
activity
18.0 (11.7-30.1) 5.3-70.0
Total counts/day 202,680 (166,951-248,344) 92,131-429,497
Average counts/min 256.3 (209.5-323.7) 131.0-615.5
Step counts/day 5,687 (4,452-7,086) 1,545-11,453
Pedometer
Step counts/day
2 5,961 (3,727-8,510) 267-12,833
1 Min/day unless otherwise specified. The values represent the average of all
valid days.
2 A normally distributed variable.
Table 3 Spearman correlation coefficients between
pedometer step counts and accelerometer measures of
physical activity (n = 58)
Correlation
coefficient
95% confidence
intervals
p-value
Sedentary time (min/day) -0.30 -0.51 to 0.05 0.023
Total activity time
(min/day)
0.40 0.13 to 0.63 0.002
Light activity (min/day) 0.36 0.10 to 0.58 0.006
Moderate or vigorous
activity (min/day)
0.47 0.18 to 0.69 <0.001
Total counts/day 0.51 0.24 to 0.72 <0.001
Average counts/min 0.54 0.28 to 0.74 <0.001
Step counts/day 0.78 0.59 to 0.90 <0.001
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0.35 for gestational age).
Agreement between categorised pedometer and
accelerometer measures of PA
Based on the accelerometer data, 15 (26%) of these
women recorded ≥30 mins MVPA/day, 12 (19%)
recorded ≥8,000 steps/day and 3 (5%) recorded ≥10,000
steps/day. The pedometer data showed that 18 (29%) of
women recorded ≥8,000 pedometer steps/day and 4
(7%) recorded ≥10,000 steps/day.
There was moderate agreement between those achiev-
ing ≥8,000 pedometer steps/day and those achieving ≥30
min MVPA/day (kappa = 0.45, 95% CI: 0.24 to 0.67)
(Table 4). Agreement between the pedometer and the
accelerometer in categorising women to <8,000 or
≥8,000 steps/day was good (kappa = 0.63, 95% CI: 0.43
to 0.83). Very few women achieved ≥10,000 steps/day
with either of the monitors (N = 3 for accelerometer
and N = 4 for pedometer), thus the agreement between
these was artificially high (results not shown).
Discussion
Large scale trials are needed to assess the potential
impact of increased PA on reducing pregnancy compli-
cations and these trials should ideally use objective
Figure 1 Daily step counts measured by accelerometer and pedometer. The figure also shows the line of equality and (least-squares) line
of best fit (n = 58).
Kinnunen et al. BMC Public Health 2011, 11:501
http://www.biomedcentral.com/1471-2458/11/501
Page 5 of 9measurement methods to measure changes in PA
[1,3,37]. Pedometers would be a cost-effective measure-
ment tool for large studies, provided that the simple
step count measure is broadly comparable to the more
specific accelerometer data. Our results show that
although there was a significant correlation between
pedometer step counts and most accelerometer mea-
sures of PA and no difference in median step counts
between the two devices, the 95% limits of agreement
were very broad, especially among those participants
who were less active. Additionally, the direction of
Figure 2 Differences in step counts/day between accelerometer and pedometer plotted against the mean of both (n = 58). The limits
of agreement were calculated using a regression method previously described by Bland & Altman [34]. The formula for the 95% limits of
agreement is: [2339-0.391 × (mean of accelerometer and pedometer)] ± 2.46 × [1201-0.019 × (mean of accelerometer and pedometer)].
Table 4 Agreement between categorised pedometer and
accelerometer measures of physical acticity, Kappa
(95% confidence intervals)
Accelerometer data
1 Kappa (accelerometer data vs.
≥8,000 pedometer step
counts/day)
2
95%
confidence
intervals
≥30 mins MVPA/day 0.45 0.24 to 0.67
≥8,000 steps/day 0.63 0.43 to 0.83
1 15 (26%) of the participants recorded ≥30 mins MVPA/day and 12 (19%)
recorded ≥8,000 steps/day.
2 18 (29%) of the participants recorded ≥8,000 pedometer steps/day.
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across the range of activity levels suggesting a compli-
cated pattern of disagreement. Agreement between the
monitors in categorising participants as active and inac-
tive varied from fair to good depending on the criteria
adopted, being good when achievement of ≥8,000 steps/
day was used as the criterion.
Pedometer step counts have been compared to accel-
erometer data in a number of previous reports
[18,20-23], all of which used one of the Actigraph/CSA/
Manufacturing Technology Inc. (MTI) accelerometer
models and one of the Yamax pedometer models, as in
the present study. These accelerometer models are not
entirely comparable to each other in measuring steps
and activity counts [38,39]. The study by Harrison et al.
[18] included 30 overweight or obese pregnant women
at 26 to 28 weeks’ g e s t a t i o ni nA u s t r a l i a .T h ep a r t i c i -
pants wore an accelerometer (GT1M Actigraph) and a
pedometer for 5 to 7 days and the accelerometer data
processing rules were very similar to those used in our
study. Despite a statistically significant correlation (r =
0.69, p < 0,01) between the step counts of each monitor,
the mean difference was 505 steps/day and the limits of
agreement were large (from -2491 to 3501 steps/day).
The other studies were not conducted in pregnant
women and generally included subjects who were more
active than our participants. However, the findings were
essentially similar to those in the present study. Tudor-
Locke et al. [20], in a study of 60 adult volunteers in
South Carolina, USA, observed a high correlation
between accelerometer (CSA model 7164) and ped-
ometer step counts (r = 0.86), but the accelerometer
detected 1845 ± 2116 more steps/day on average than
the pedometer and the limits of agreement were even
broader (-2387 to 6077 steps/day) than reported in the
present study. In a larger study of older adults in the
UK (n = 121) [23], Harris et al. reported that pedometer
step counts were highly correlated to the accelerometer
(Actigraph GT1M) step counts (r = 0.86) and the mean
step counts were similar. However, the limits of agree-
ment were again large, around -3500 to 3500 [23].
Ramirez-Marrero et al. [22] reported similar findings
among 58 adults with HIV in Puerto Rico. Although the
limits of agreement were not calculated in that study,
individual variation in differences in step counts seemed
to be large. When comparing pedometer step counts to
other accelerometer (Actigraph model 7164) measures
of PA, the correlations observed in the present study are
generally similar, although weaker than in the previous
studies [20,22,23]. Macfarlane et al. [21] observed
among 57 adult volunteers in Hong Kong that the
means for accelerometer (MTI model 7164) measures of
PA increased with increasing pedometer step counts,
but the confidence intervals were broad.
Amongst the previous studies, Tudor-Locke et al. [20]
were the only authors to conclude that agreement
between pedometer step counts and accelerometer mea-
sures of PA was unacceptably low, despite others also
reporting broad limits of agreement [18,23] or confi-
dence intervals [21]. Future studies should pay more
attention to correct interpretation of Bland-Altman
plots and limits of agreement.
The present study confirms the findings of these stu-
dies in a sample of 58 overweight and obese pregnant
women. Although there are currently no methods avail-
able to calculate 95% confidence intervals for the limits
of agreement determined by a regression based method,
it is important to note that a larger sample size would
not have affected the size of the limits of agreement.
There are also no guidelines for acceptable 95% limits of
agreement for step counts. We propose that they should
be no larger than ± 500 steps/day (i.e. a range of 1000
steps/day), which is likely to correspond to a maximum
of 10 min difference in the duration of MVPA, such as
brisk walking [33], and may therefore be of clinical and
public health importance.
The difference between the accelerometer and the
pedometer step counts was correlated to the mean of
both measures in the present study, but not in the
others [18,20,23]. In this study, the difference between
the step counts was in the opposite direction for less
active and more active women, i.e. accelerometer detect-
ing more steps among less active women and pedometer
detecting more steps among more active women. This
discrepancy may be related to the general limitations of
the monitors or differences in their sensitivity to detect
PA. Pedometer accuracy is reported to be diminished at
slow walking speeds, especially below 3 miles/h [31,40]
and both active and inactive participants undertook
many episodes of light intensity activity in the present
study. This may also be the case with some acceler-
ometers, although the GT1M model used in our study
has been shown to have lower intermonitor variability
and lower sensitivity for light intensity activity than the
preceding 7164 model [38,39]. On the other hand, the
previous CSA model has also been reported to erro-
neously detect slightly more nonsteps e.g. when travel-
ling by a motor vehicle [41].
The accuracy of the latest Actigraph accelerometer
model (GT3X) and Yamax Digiwalker SW-200 was
recently investigated in 30 pregnant women [19]. Both
monitors underestimated the number of steps especially
at slow walking speeds, but positioning the monitors at
a tilt angle did not correlate with the percentage of
actual steps detected by either monitor. In contrast,
Crouter et al. [31] suggested that the tilt angle reduced
the accuracy of spring-levered pedometers in overweight
or obese adults. The tilt angle may also reduce the
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ment, which may happen more often among overweight
and obese than normal weight people [17]. The tilt
angle was not directly measured in the present study.
However, BMI and gestational age did not significantly
modify the results of the Bland-Altman plot suggesting
that the potential effect of the tilt angle on the results
may have been the same regardless of BMI or gesta-
tional age.
We also assessed agreement between the monitors in
categorising participants as active or inactive. Whilst
agreement was relatively good (Kappa 0.63) when using
8,000 steps/day as the criterion for both monitors,
agreement was lower (Kappa 0.45) when comparing
participants achieving 8,000 pedometer steps/day to
those achieving 30 min of MVPA/day measured by
accelerometer. Of the previous studies, Ramirez-Mar-
rero et al. [22] reported fair agreement between 10,000
pedometer steps/day and 150 min MVPA/week (Kappa
0.25, p = 0.01). These discrepancies between pedometer
and accelerometer in categorising participants into
active and inactive may partly be due to the data pro-
cessing rules, such as selection of the epoch length and
intensity cut points to define MVPA for the acceler-
ometer data.
Accelerometry should not be regarded as a gold stan-
dard to measure free-living PA nor necessarily as a
more accurate method of measuring daily steps than
pedometer. Although the previous version of the Acti-
graph accelerometer the only commercially available
a c c e l e r o m e t e r[ 2 8 ]t h a tc o r r e l a t e dr e a s o n a b l yw i t hd o u -
bly labelled water, most validation studies have been
conducted in controlled environments. Validity is lower
when applied to free-living settings [17]. Two armband
accelerometers have also recently been shown to be
highly correlated with doubly labelled water in free-liv-
ing conditions [42]. Both the accelerometer and the ped-
ometer measure biomechanical body movement. Hence,
validity of the monitors against energy expenditure
should not be a major concern when assessing agree-
ment between these devices.
This study had some limitations. Firstly, although the
participants were asked to record the times when they
wore the monitors, we cannot be sure that both moni-
tors were worn exactly for the same time. Some women
had very low pedometer step counts but moderate
accelerometer step counts suggesting that the wearing
time may have been different for each monitor or the
pedometer may have been in a tilt angle. Therefore, stu-
dies in controlled conditions, such as by Connolly et al.
[19], would be necessary to be certain that monitors
were worn for exactly the same time. Secondly, almost
all of our participants were in the first or second trime-
ster of pregnancy and therefore we do not know
whether the results can be generalized to the third tri-
mester, when activity decreases and the abdominal cir-
cumference is much larger. On the other hand, these
results may be generalized to non-pregnant overweight
and obese women of similar age.
Thirdly, participation was low (33%) and 34% of the
participants were excluded because of fewer than three
valid days of accelerometer data. The activity levels of
the participants were similar or slightly lower than those
reported in pregnant women in other comparable stu-
dies [5,6,16,43]. The purpose of this study, however, was
to compare methods of measurement, rather than
obtain representative estimates of PA levels in
pregnancy.
Conclusions
Comparing median step counts or assessing correlation
coefficients over-estimates agreement between ped-
ometer and accelerometer data. Examination of the 95%
limits of agreement revealed a substantial lack of agree-
ment between step counts measured by the two types of
monitor. Pedometer step counts were not comparable to
accelerometer data at an individual level in overweight
and obese pregnant women. The choice of measurement
method may depend on the target of the intervention.
For example, accelerometers may be better at assessing
changes in PA in trials which promote increases in
moderate or vigorous PA or reduction in sedentary time
while spring-levered pedometers may be more appropri-
ate for studies evaluating walking interventions in more
active populations.
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